AST

Activities: Pharmaceutical

Visit website

Profile

Trending Articles

  1. Musk confirms Tesla will retain control of Terafab despite TSMC talks Tesla and SpaceX will build and operate the planned Texas semiconductor fab, with TSMC potentially leasing part of the facility, Musk says
  2. UV Medico installs operator decontamination system at European pharma facility The Danish manufacturer of filtered UVC systems has installed a UV222 Wall at a European pharmaceutical facility, adding a 20-second Far-UVC personnel decontamination step at...
  3. Former SK hynix semiconductor fab with 170,000 sqft of cleanroom space hits the market in Oregon A former semiconductor manufacturing facility in Eugene, Oregon, includes existing cleanroom, utility and process infrastructure and is being marketed for semiconductor and...
  4. SK hynix approves $38bn investment in two new memory fabs The semiconductor manufacturer has approved construction of a DRAM plant at the Yongin Semiconductor Cluster and a NAND flash facility, with new cleanrooms expected to be...
  5. Musk confirms fourth SpaceXAI data centre in Memphis as illegal gas turbines begin to come down Elon Musk has confirmed plans for a fourth data centre in the Memphis area as the company begins removing gas turbines at its existing Colossus campus

Upcoming event

Semicon West

13–15 October 2026 | Exhibition | San Francisco, California See all

Related Content

Pharmaceutical
AST Names industry veteran Jon Lenihan as Chief Commercial Officer

AST Names industry veteran Jon Lenihan as Chief Commercial Officer

Jon to lead business development, marketing and communications, strengthening AST’s Executive Leadership Team
Containment
The state of automative technologies in biopharmaceutical manufacturing in 2026

The state of automative technologies in biopharmaceutical manufacturing in 2026

Steven Ng and Josh Russell from AST discuss the types of automative technologies that are being realistically implemented in biopharma in 2026
Containment
AST’s latest generation GENiSYS R: available with accelerated delivery

AST’s latest generation GENiSYS R: available with accelerated delivery

Available with an accelerated delivery schedule, AST’s GENiSYS R is a fully integrated solution for the production of high-value liquid pharmaceuticals
You need to be a subscriber to read this article.
Click here to find out more.
Pharmaceutical
10 common pitfalls in cell and gene therapy facility design, and how to avoid them

10 common pitfalls in cell and gene therapy facility design, and how to avoid them

Jason Rossi from AST reviews ten common mistakes in CGT facility design, from not being realistic about heat load, to not accounting for process bottlenecks
Design & Build
AST and Marchesini Group showcase aseptic fill-finish innovations at INTERPHEX 2026

AST and Marchesini Group showcase aseptic fill-finish innovations at INTERPHEX 2026

The companies demonstrated integrated aseptic processing technologies, inspection systems and CQV expertise at this year’s INTERPHEX event in New York City
Hi Tech Manufacturing
AST and Marchesini Group debut partnership benefit with expanded drug product manufacturing portfolio at INTERPHEX 2026

AST and Marchesini Group debut partnership benefit with expanded drug product manufacturing portfolio at INTERPHEX 2026

Partnership showcases integrated aseptic technologies and end-to-end fill-finish and inspection solutions for sterile pharmaceutical manufacturing
Containment
AST origins: pioneering RTU flexibility with robotic fill-finish systems

AST origins: pioneering RTU flexibility with robotic fill-finish systems

How ASEPTiCell transformed aseptic processing for multi-format sterile products
Subscribe now